1-3 of 3
Jian Jin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma

Shashidhar S. Jatiani, Stephanie Christie, Violetta V. Leshchenko, Rinku Jain, Abhijeet Kapoor, Paola Bisignano, Clement Lee, H. Ümit Kaniskan, Donna Edwards, Fanye Meng, Alessandro Laganà, Youssef Youssef, Adrian Wiestner, Lapo Alinari, Jian Jin, Marta Filizola, Aneel K. Aggarwal, Samir Parekh
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4652–4663.
https://doi.org/10.1158/1078-0432.CCR-20-5039
Published: 15 August 2021
View article titled, SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma
Open the PDF for SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition

Ola Rizq, Naoya Mimura, Motohiko Oshima, Atsunori Saraya, Shuhei Koide, Yuko Kato, Kazumasa Aoyama, Yaeko Nakajima-Takagi, Changshan Wang, Tetsuhiro Chiba, Anqi Ma, Jian Jin, Tohru Iseki, Chiaki Nakaseko, Atsushi Iwama
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (16): 4817–4830.
https://doi.org/10.1158/1078-0432.CCR-16-2735
Published: 14 August 2017
View article titled, Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition
Open the PDF for Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition in another window
Includes: Supplementary data
Journal Articles

Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models

Patrick J. Roberts, Jerry E. Usary, David B. Darr, Patrick M. Dillon, Adam D. Pfefferle, Martin C. Whittle, James S. Duncan, Soren M. Johnson, Austin J. Combest, Jian Jin, William C. Zamboni, Gary L. Johnson, Charles M. Perou, Norman E. Sharpless
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5290–5303.
https://doi.org/10.1158/1078-0432.CCR-12-0563
Published: 30 September 2012
View article titled, Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models
Open the PDF for Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models in another window
Includes: Supplementary data